Yasuo Ikeda

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.

Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.

Journal: Stroke

Published: February 10, 2021

A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder.

A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder.

Journal: Blood advances

Published: November 13, 2020

Platelet production using adipose-derived mesenchymal stem cells: Mechanistic studies and clinical application.

Platelet production using adipose-derived mesenchymal stem cells: Mechanistic studies and clinical application.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 24, 2020

Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial.

Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial.

Journal: Journal of atherosclerosis and thrombosis

Published: June 05, 2020

Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II.

Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II.

Journal: Cerebrovascular diseases (Basel, Switzerland)

Published: November 15, 2019

Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial.

Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial.

Journal: Journal of thrombosis and thrombolysis

Published: October 24, 2019

Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study.

Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study.

Journal: Heart and vessels

Published: May 15, 2019

Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks.

Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks.

Journal: Journal of hypertension

Published: April 26, 2019

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70).

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70).

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: December 20, 2018

Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).

Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).

Journal: The Lancet. Neurology

Published: August 08, 2018

Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel.

Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel.

Journal: Journal of thrombosis and thrombolysis

Published: August 04, 2018

Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.

Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.

Journal: Blood

Published: April 11, 2018

Showing 1-12 of 47

Last Updated: 09/26/2026